| Date |
Report No. |
Title |
| Date July 14, 2005 |
Report No. GAO-05-733R |
Title
United States Government Accountability Office Washington, DC 20548 July 14, 2005 The Honorable Michael O. Leavitt The Secretary of Health and Human Services Subject: Medicare: Radiopharmaceutical Purchase Prices for CMS Consideration in Hospital Outpatient Rate-Setting
Dear Mr. Secretary: In our recent report on hospital outpatient drug purchase prices, Medicare: Drug Purchase Prices for CMS Cons... |
| Date June 22, 2005 |
Report No. GAO-05-555 |
Title
United States Government Accountability Office GAO
June 2005 Report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Veterans’ Affairs, House of Representatives MAIL ORDER PHARMACIES DOD’s Use of VA’s Mail Pharmacy Could Produce Savings and Other Benefits GAO-05-555 June 2005 MAIL ORDER PHARMACIES Highlights
Highlights of GAO-05-555, a report to the Chairman, Subco... |
| Date June 22, 2005 |
Report No. GAO-05-850T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 2:00 p.m. EDT Wednesday, June 22, 2005 Testimony Before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives MEDICAID DRUG REBATE PROGRAM Inadequate Oversight Raises Concerns about Rebates Paid to States
Statement of Kathleen King Director, Health Care GAO-05-850T June 22, 2005 ... |
| Date Feb. 4, 2005 |
Report No. GAO-05-102 |
Title
United States Government Accountability Office GAO
February 2005 Report to Congressional Requesters MEDICAID DRUG REBATE PROGRAM Inadequate Oversight Raises Concerns about Rebates Paid to States GAO-05-102 February 2005 MEDICAID DRUG REBATE PROGRAM Highlights
Highlights of GAO-05-102, a report to congressional requesters Accountability Integrity Reliability Inadequate Oversight Raises Concerns abo... |
| Date Nov. 18, 2004 |
Report No. GAO-05-177T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 9:30 a.m. EST Thursday, November 18, 2004 Testimony Before the Subcommittee on Health and the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives FLU VACCINE Recent Supply Shortages Underscore Ongoing Challenges
Statement of Janet Heinrich Director, Health Car... |
| Date Oct. 12, 2004 |
Report No. GAO-05-72 |
Title
United States Government Accountability Office GAO
October 2004 Report to Congressional Committees MEDICARE Appropriate Dispensing Fee Needed for Suppliers of Inhalation Therapy Drugs GAO-05-72 a October 2004 MEDICARE Highlights
Highlights of GAO-05-72, a report to congressional committees Accountability Integrity Reliability Appropriate Dispensing Fee Needed for Suppliers of Inhalation Therapy Dr... |
| Date Oct. 6, 2004 |
Report No. GAO-05-104R |
Title
United States Government Accountability Office Washington, DC 20548 October 6, 2004 The Honorable Olympia J. Snowe Chair Committee on Small Business and Entrepreneurship United States Senate The Honorable Ron Wyden Ranking Minority Member Subcommittee on Consumer Affairs and Product Safety Committee on Commerce, Science, and Transportation United States Senate Subject: Prescription Drugs: Trends i... |
| Date June 17, 2004 |
Report No. GAO-04-892T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 9:00 a.m. EDT Thursday, June 17, 2004 Testimony
Before the Permanent Subcommittee on Investigations, Committee on Governmental Affairs, U.S. Senate INTERNET PHARMACIES Hydrocodone, an Addictive Narcotic Pain Medication, Is Available Without a Prescription Through the Internet
Statement of Robert J. Cramer Managing Dire... |
| Date June 17, 2004 |
Report No. GAO-04-820 |
Title
United States General Accounting Office GAO
June 2004 Report to the Chairman, Permanent Subcommittee on Investigations, Committee on Governmental Affairs, U.S. Senate INTERNET PHARMACIES Some Pose Safety Risks for Consumers GAO-04-820 a June 2004 INTERNET PHARMACIES Some Pose Safety Risks for Consumers
Highlights of GAO-04-820, a report to the Chairman, Permanent Subcommittee on Investigations, Co... |
| Date June 17, 2004 |
Report No. GAO-04-888T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 9:00 a.m. EDT Thursday, June 17, 2004 Testimony Before the Permanent Subcommittee on Investigations, Committee on Governmental Affairs, U.S. Senate INTERNET PHARMACIES Some Pose Safety Risks for Consumers and Are Unreliable in Their Business Practices
Statement of Marcia Crosse Director, Health Care—Public Health and... |
| Date March 4, 2004 |
Report No. GAO-04-524T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 1:00 p.m. EST Thursday, March 4, 2004 Testimony Before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives PRESCRIPTION DRUGS State Monitoring Programs May Help to Reduce Illegal Diversion
Statement of Marcia Crosse Director, Health Care—Public Health and Military Health Care Issues... |
| Date Oct. 23, 2003 |
Report No. GAO-04-195T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Thursday, October 23, 2003 Testimony Before the Committee on Health, Education, Labor, and Pensions, U.S. Senate PRESCRIPTION DRUGS State and Federal Oversight of Drug Compounding by Pharmacies
Statement of Janet Heinrich Director, Health Care—Public Health Issues GAO-04-195T October 23, 2003 PRESCRIPTION ... |
| Date Sept. 26, 2003 |
Report No. GAO-03-950 |
Title
United States General Accounting Office GAO
September 2003 Report to Congressional Committees PEDIATRIC DRUG RESEARCH Food and Drug Administration Should More Efficiently Monitor Inclusion of Minority Children GAO-03-950 September 2003 PEDIATRIC DRUG RESEARCH Food and Drug Administration Should More Efficiently Monitor Inclusion of Minority Children Highlights of GAO-03-950, a report to the Commit... |
| Date June 4, 2003 |
Report No. GAO-03-829 |
Title
United States General Accounting Office GAO
June 2003 Report to the Honorable Ron Wyden, U.S. Senate TECHNOLOGY TRANSFER NIH-Private Sector Partnership in the Development of Taxol GAO-03-829 Contents Letter
Results in Brief Background NIH-BMS Partnership Provided Research Results Critical to Developing Taxol’s Commercial Uses NIH Invested Heavily in Taxol-Related Research, but Federal Financial ... |
| Date Jan. 10, 2003 |
Report No. GAO-03-196 |
Title
United States General Accounting Office GAO
January 2003 Report to the Honorable Byron L. Dorgan, U.S. Senate FEDERAL EMPLOYEES’ HEALTH BENEFITS Effects of Using Pharmacy Benefit Managers on Health Plans, Enrollees, and Pharmacies GAO-03-196 January 2003 FEDERAL EMPLOYEES’ HEALTH BENEFITS
Highlights of GAO-03-196, a report to the Honorable Byron L. Dorgan, U.S. Senate Effects of Using Pharmacy... |
| Date Oct. 28, 2002 |
Report No. GAO-03-177 |
Title
United States General Accounting Office GAO
October 2002 Report to Congressional Requesters PRESCRIPTION DRUGS FDA Oversight of Direct-to-Consumer Advertising Has Limitations GAO-03-177 Contents Letter
Results in Brief Background Pharmaceutical Companies Spend More on Research and Development than on DTC Advertising DTC Advertising Appears to Increase Prescription Drug Spending and Utilization FDA... |
| Date Sept. 27, 2002 |
Report No. GAO-02-1017 |
Title
United States General Accounting Office GAO
September 2002 Report to Chairman, Subcommittee on Defense, Committee on Appropriations, U.S. Senate VA AND DEFENSE HEALTH CARE Increased Risk of Medication Errors for Shared Patients GAO-02-1017 Contents Letter
Results in Brief Background Shared Patients Obtain Inpatient Drugs from the Treating Agency but Generally Return to Home Agency for Outpatient D... |
| Date Sept. 17, 2002 |
Report No. GAO-02-958 |
Title
United States General Accounting Office GAO
September 2002 Report to the Chairman, Committee on Health, Education, Labor, and Pensions, U.S. Senate FOOD AND DRUG ADMINISTRATION Effect of User Fees on Drug Approval Times, Withdrawals, and Other Agency Activities GAO-02-958 Contents Letter
Results in Brief Background PDUFA Has Increased Funding and Reduced Drug Approval Time, but Biologic Approval T... |
| Date June 26, 2002 |
Report No. GAO-02-872T |
Title
United States General Accounting Office GAO Testimony
Before the Subcommittee on Health, Committee on Veterans’ Affairs, House of Representatives For Release on Delivery Expected at 9:30 a.m. Wednesday, June 26, 2002 VA AND DEFENSE HEALTH CARE Potential Exists for Savings through Joint Purchasing of Medical and Surgical Supplies
Statement of Cynthia A. Bascetta Director, Health Care—Veterans... |
| Date May 17, 2002 |
Report No. GAO-02-634 |
Title
United States General Accounting Office GAO
May 2002 Report to the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives PRESCRIPTION DRUGS State Monitoring Programs Provide Useful Tool to Reduce Diversion GAO-02-634 Contents Letter
Results in Brief Background PDMPs Vary in Objectives, Design, and Operation State Programs Have Helped Shorten Inves... |
| Date March 14, 2002 |
Report No. GAO-02-531T |
Title
United States General Accounting Office GAO Testimony
Before the Subcommittee on Health, Committee on Finance, U.S. Senate For Release on Delivery Expected at 10:00 a.m. Thursday, March 14, 2002 MEDICARE OUTPATIENT DRUGS Program Payments Should Better Reflect Market Prices
Statement of Laura A. Dummit Director, Health Care—Medicare Payment Issues GAO-02-531T Mr. Chairman and Members of the Subco... |
| Date Dec. 5, 2001 |
Report No. GAO-02-280R |
Title
United States General Accounting Office Washington, DC 20548 December 5, 2001 Congressional Requesters Subject: Prescription Drugs: Prices Available Through Discount Cards and From Other Sources This letter responds to your request for information on how the prices for prescription drugs purchased using drug discount cards compare with the prices available at local pharmacies or over the Internet.... |
| Date July 6, 2001 |
Report No. GAO-01-754 |
Title
United States General Accounting Office GAO
July 2001 Report to Congressional Requesters WOMEN’S HEALTH Women Sufficiently Represented in New Drug Testing, but FDA Oversight Needs Improvement GAO-01-754 Contents Letter
Results in Brief Background FDA’s Regulation Not As Specific As Earlier Guidance NDA and IND Submissions Often Fail to Present Required Information NDAs Include Appropriate Numb... |
| Date May 25, 2001 |
Report No. GAO-01-588 |
Title
United States General Accounting Office GAO
May 2001 Report to Congressional Requesters DOD AND VA PHARMACY Progress and Remaining Challenges in Jointly Buying and Mailing Out Drugs GAO-01-588 Contents Letter Appendix I Status of VA and DOD Pharmaceutical Procurements 1 32 Appendix II Planned DOD and VA Joint Procurements 39 Appendix III VA’s CMOP Program 44 Appendix IV Comments From the Departm... |
| Date May 8, 2001 |
Report No. GAO-01-705T |
Title
United States General Accounting Office GAO Testimony
Before the Committee on Health, Education, Labor and Pensions, U.S. Senate For Release on Delivery Expected at 9:30 a.m. Tuesday, May 8, 2001 PEDIATRIC DRUG RESEARCH Substantial Increase in Studies of Drugs for Children, But Some Challenges Remain
Statement of Janet Heinrich Director, Health Care—Public Health Issues GAO-01-705T Chairman Jeff... |
| Date Nov. 16, 2000 |
Report No. GAO-01-137 |
Title
United States General Accounting Office GAO
November 2000 Report to Congressional Requesters PRESCRIPTION DRUGS Drug Company Programs Help Some People Who Lack Coverage GAO-01-137 Contents Letter Appendix Tables
Appendix I: Scope and Methodology 3 16 Table 1: Reported Annual Income Limits for Eligibility in Patient Assistance Programs, 1998 Table 2: Programs Offering and Requiring Applications for... |
| Date Oct. 31, 2000 |
Report No. GAO-01-175R |
Title
United States General Accounting Office Washington, DC 20548 ERRATA Drug Prices Paid by DOD and VA Are, on Average, Lower Than Those Certified to HCFA as Best Price GAO-01-175R October 31, 2000 This correspondence has been modified to include technical clarifications. Robert H. Hast Managing Director Office of Special Investigations United States General Accounting Office Washington, DC 20548 Octo... |
| Date Oct. 19, 2000 |
Report No. GAO-01-69 |
Title
United States General Accounting Office GAO
October 2000 Report to Congressional Requesters INTERNET PHARMACIES Adding Disclosure Requirements Would Aid State and Federal Oversight GAO-01-69 Contents Letter Appendixes
Appendix I: Scope and Methodology 3 30 Appendix II: Actions by 28 States to Regulate Internet Pharmacies and Physicians Prescribing on the Basis of an Online Questionnaire Appendix I... |
| Date Sept. 6, 2000 |
Report No. HEHS-00-162 |
Title
United States General Accounting Office GAO
September 2000 Report to Congressional Requesters STATE PHARMACY PROGRAMS Assistance Designed to Target Coverage and Stretch Budgets GAO/HEHS-00-162 Contents Letter Appendixes Tables
Appendix I: Scope and Methodology 3 26 Table 1: State Pharmacy Assistance Programs, Years Enacted and Operational 7 Table 2: Eligibility Requirements for State Pharmacy Assi... |
| Date Aug. 10, 2000 |
Report No. HEHS-00-140 |
Title
United States General Accounting Office GAO
August 2000 Report to Congressional Requesters PRESCRIPTION DRUGS Many Factors Affected FDA’s Approval of Selected “Pipeline” Drugs GAO/HEHS-00-140 Contents Letter Appendixes
Appendix I: Scope and Methodology 3 26 29 32 45 49 Appendix II: Approval Time Comparisons Appendix III: Approval Process for Claritin Appendix IV: Approval Process for Relafen... |
| Date Aug. 7, 2000 |
Report No. HEHS-00-118 |
Title
United States General Accounting Office GAO
August 2000 Report to Congressional Requesters PRESCRIPTION DRUGS Expanding Access to Federal Prices Could Cause Other Price Changes GAO/HEHS-00-118 Contents Letter Tables
Table 1: Pharmaceutical Pricing Terms Table 2: Prices for Select Prescription Drugs Commonly Used by the Elderly, February 2000 3 9 12 Abbreviations AMP AWP CBO DOD FCP FSS GSA HCFA HM... |
| Date May 25, 2000 |
Report No. T-HEHS-00-121 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Thursday, May 25, 2000 Testimony
Before the Subcommittee on Oversight and Investigations, Committee on Veterans’ Affairs, House of Representatives DOD AND VA HEALTH CARE Jointly Buying and Mailing Out Pharmaceuticals Could Save Millions of Dollars
Statement of Stephen P. Backhus, Director Veterans’ Affai... |
| Date May 11, 2000 |
Report No. T-HEHS-00-112 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 9:30 a.m. Thursday, May 11, 2000 Testimony
Before the Subcommittee on Health, Committee on Ways and Means, House of Representatives PRESCRIPTION DRUGS Adapting Private Sector Management Methods for a Medicare Benefit
Statement of William J. Scanlon, Director Health Financing and Public Health Issues Health, Education, ... |
| Date March 22, 2000 |
Report No. T-HEHS-00-84 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Wednesday, March 22, 2000 Testimony
Before the Committee on Finance, U.S. Senate PRESCRIPTION DRUG BENEFITS Applying Private Sector Management Methods to Medicare
Statement of William J. Scanlon, Director Health Financing and Public Health Issues Health, Education, and Human Services Division GAO/T-HEHS-00-8... |
| Date Dec. 14, 1999 |
Report No. HEHS-00-34 |
Title
United States General Accounting Office GAO
December 1999 Report to the Ranking Minority Member, Committee on Veterans’ Affairs, U.S. Senate VA HEALTH CARE VA’s Management of Drugs on Its National Formulary GAO/HEHS-00-34 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-283993 December 14, 1999 The Honorable John D. Rockefeller... |
| Date Oct. 28, 1999 |
Report No. T-AIMD-00-39 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10 a.m. Thursday, October 28, 1999 Testimony
Before the Subcommittee on Oversight and Investigations, Committee on Veterans’ Affairs, House of Representatives YEAR 2000 COMPUTING CHALLENGE Update on the Readiness of the Department of Veterans Affairs
Statement of Joel C. Willemssen Director, Civil Agencies Informatio... |
| Date Sept. 28, 1999 |
Report No. T-HEHS-99-198 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Tuesday, September 28, 1999 Testimony
Before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives MEDICARE Beneficiaries’ Prescription Drug Coverage
Statement of Laura A. Dummit, Associate Director Health Financing and Public Health Issues Health, Education, and Human... |
| Date Aug. 13, 1999 |
Report No. HEHS-99-143R |
Title
GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-233090 August 13,1999 The Honorable Thomas J. Bliley, Jr. Chairman The Honorable John D. Dingell Ranking Minority Member Committee on Commerce House of Representatives The Honorable Fred Upton Chairman The Honorable Ron Klink Ranking Minority Member Subcommittee on Oversight and Inve... |
| Date June 23, 1999 |
Report No. T-HEHS-99-153 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Wednesday, June 23, 1999 Testimony
Before the Committee on Finance, U.S. Senate MEDICARE Considerations for Adding a Prescription Drug Benefit
Statement of Laura A. Dummit, Associate Director Health Financing and Public Health Issues Health, Education, and Human Services Division GAO/T-HEHS-99-153 Medicare: ... |
| Date June 8, 1999 |
Report No. HEHS-99-134R |
Title
GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-282860 June 8, 1999 The Honorable Don Nickles United States Senate Subject: Defense Health Care: Pharmacy Copavments Dear Senator Nickles: This responds to your March 17, 1999, referral to us of a letter that several constituents sent you regarding our recent report and testimony on ... |
| Date April 20, 1999 |
Report No. T-AIMD-99-152 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 2:30 p.m. Tuesday, April 20, 1999 Testimony
Before the Committee on Veterans’ Affairs, U.S. Senate YEAR 2000 COMPUTING CRISIS Key Actions Remain to Ensure Delivery of Veterans Benefits and Health Services
Statement of Joel C. Willemssen Director, Civil Agencies Information Systems Accounting and Information Managemen... |
| Date March 10, 1999 |
Report No. T-HEHS-99-75 |
Title
GAO
For Release on Delivery Expected at 1:00 p.m. EST Wednesday, March 10, 1999 United States General Accounting Office Testimony Before the Subcommittee on Military Personnel, Committee on Armed Services, House of Representatives DEFENSE HEALTH CARE Need for Top-to-Bottom Redesign of Pharmacy Programs
Statement of Stephen P. Backhus, Director Veterans Affairs and Military Health Care Issues Hea... |
| Date Feb. 26, 1999 |
Report No. HEHS-99-71R |
Title
GAO United States General Accounting Office Washington, D.C. 20548 Health, Human Education, and Services Division B-281553 February 26,1999 The Honorable Thomas J. Bliley, Jr. Chairman The Honorable John D. Dmgell Ranking Minority Member Committee on Commerce House of Representatives The Honorable Fred Upton Chah-IUal-l The Honorable Ron Klink Ranking Minorily Member Subcommittee on Oversight and ... |
| Date Nov. 16, 1998 |
Report No. HEHS-99-16R |
Title
GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-279966 November 16, 1998 The Honorable William M. Thomas Chairman, Subcommittee on Health Committee on Ways and Means House of Representatives The Honorable Philip M. Crane House of Representatives Subject: Medicare: Coverage of Pumas Used to Administer Intravenous Drugs Medicare’ ... |
| Date June 12, 1998 |
Report No. HEHS-98-176 |
Title
United States General Accounting Office GAO
June 1998 Report to Congressional Committees DEFENSE HEALTH CARE Fully Integrated Pharmacy System Would Improve Service and Cost-Effectiveness GAO/HEHS-98-176 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-277613 June 12, 1998 The Honorable Dirk Kempthorne Chairman The Honorable Max Cle... |
| Date March 17, 1998 |
Report No. HEHS-98-21 |
Title
United States General Accounting Office GAO
March 1998 Report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives FOOD AND DRUG ADMINISTRATION Improvements Needed in the Foreign Drug Inspection Program GAO/HEHS-98-21 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-275814 M... |
| Date Sept. 1, 1997 |
Report No. AA-97-14(3) |
Title
|
| Date July 21, 1997 |
Report No. HEHS-97-190R |
Title
GAO united
states General Accounting Offlce Washington, D.C. 20648 Heal@ EMucation and Human !Services Division B-277557 July 21, 1997 The Honorable James Jeffords Chairman Committee on Labor and Human Resources United States Senate Dear Chairman Jeffords: Subject: PDUFA: The Prescription Drug User Fee Act of 1992 (PDUFA) authorizes the Food and Drug Administration (FDA) to collect fees from the p... |
| Date July 10, 1997 |
Report No. T-HEHS-97-171 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 9:30 a.m. Thursday, July 10, 1997 Testimony
Before the Subcommittee on Health, Committee on Veterans’ Affairs, House of Representatives FEDERAL DRUG PRICES Effects of Opening the Pharmaceutical Schedule Are Uncertain
Statement of Bernice Steinhardt, Director Health Services Quality and Public Health Issues Health, Ed... |
| Date June 11, 1997 |
Report No. HEHS-97-60 |
Title
United States General Accounting Office GAO
June 1997 Report to Congressional Committees and the Administrator of General Services DRUG PRICES Effects of Opening Federal Supply Schedule for Pharmaceuticals Are Uncertain GAO/HEHS-97-60 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-276585 June 11, 1997 The Honorable Fred Thompson,... |
